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Abstract: Vitamin D is relevant to several processes in the body mainly in the intracellular mechanisms affecting 
parathyroid hormone and calcitonin regulation, regulation of vitamin D production by negative feedback and 
calciwn and phosphorous level regulation. Vitamin D may be synthesised in the dennallayer of the skin or 
absorbed through the diet and utilised. Its biosynthesis initiates from cholesterol and its derivatives and is 
followed by a cascade of reactions, completed in the kidneys and transported via the blood to where it is 
utilized. The vitamin D receptor determines the physiological effects of vitamin D and any mutations will cause 
imbalances in bone homeostasis. 
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INTRODUCTION 
Vitamin D is mainly synthesised by the skin when 
exposed to ultraviolet rays. It can also be obtained 
through the diet as it is fOlllld in oily fish, eggs and 
fortified cow's milk. The active fonn of vitamin D binds to 
Vitamin D Receptors (VDRs) receptors located in bone, 
the intestines, kidneys, parathyroids and also 
haematopoietic tissue, cells of the immlllle system, the 
prostate in males and several other locations in the body 
where it helps normal fllllction to occur (Deluca and 
Cantoma, 2001). Ligand binding to fhe VDR causes 
heterodimerisation in conjllllction with the retinoic X 
receptor in the nucleus to occur, leading to binding 
of the heterodimer to vitamin D response elements 
(Costanzo, 2006). This vitamin D receptor complex 
transcriptionally activates genes including calciwn 
binding genes. The actions of these transcribed genes 
cause absorption of calciwn and phosphate ions. Vitamin 
D increases calciwn entIy into cells, movement of calciwn 
through cytoplasm and transfer of calciwn into the 
circulation. Serum calciwn levels are regulated by 
combined action of vitamin D and parathyroid 
hormone (Bronuer and Pansu, 1999). 
BIOSYNTHESIS 
Biosynthesis of vitamin D occurs in a series of steps 
starting from cholesterol being oxidised to provitamin D. 
Provitamin D is converted to 7 -hydrochlesterol by IN 
light followed by conversion to pre-vitamin D. This is 
converted by reversible thermal conversion to vitamin D3 
in the skin which is also known as cholecalciferol. 
Mechanisms are present to prevent overproduction of 
vitamin D3 during overexposure to swliight since excess 
vitaminD3 is converted to inactive compollllds. Vitamin D 
Binding Protein (VDBP) takes up vitamin D, in fhe 
blood to the liver where it is converted to 25-
hydroxycholecalciferol (2S-(OH)D,). This is taken up by 
the blood and reaches the kidneys where it is converted 
to 1,2S-dihydroxycholecalciferol (l,2S-(OH),D,); fhe active 
metabolite of vitamin D and 24,2S-dihydroxychole-
calciferol which is inactive (Costanzo, 2006). Vitamin D2 
originating from ergosterol in plants, a dietary supplement 
is metabolised in a similar way (Passeri et al., 2008). 
Transcriptional regulation of vitamin D3: The levels of 
2S-(OH)D, are regulated by a negative feedback response 
which inhibits its production from vitamin D3. This is 
important since the converted form of vitamin D is not 
stored and has a half-life of 2 weeks as opposed to the 
vitamin D3 form which can be stored in the liver for 
months. Parathyroid Hormone (PTH) controls the 
production of 1,25-(OH)2D3 in the proximal convoluted 
tubules. The conversion of 2S-(OH)D, to 1,2S-(OH),D, is 
almost entirely dependent upon PTH. Calciwn itself 
inhibits the formation of 1,25-(OH)2D3 and since it 
suppresses PTH secretion, calciwn also causes indirect 
inhibition of the active metabolite formation. In higher 
plasma concentrations, calciwn also promotes formation 
of inactive 24,25-dihydroxycholecalciferol which is useful 
since less Ca uptake from bone, the small intestine and 
distal renal tubules occurs, bringing serum Ca back to 
normal levels arouud 9.4 mg dL -, (Guyton audHall, 200S) 
(Fig. 1). 
The red lines indicate feedback inhibition of 
parathyroid hormone and 1 a-hydroxylase whilst the 
green positive sign and red negative sign show 
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Fig. 1: The sources of vitamin D in the diet and the main processes of vitamin D synthesis, metabolism and its effects 
on the intestine and bone 
enhancement and inhibition of 1 a-hydroxylase. Receptor 
Activator for Nuclear KB (RANK) stimulates osteoclastic 
activity in bone (http://www.jci.org/articles/view/29449/ 
figure/3). 
Actions of vitamin D: The actions of vitamin D in its 
active hormone form are various and more of its 
importance in the body is being discovered such as in the 
reproductive especially prostate metabolism and immlllle 
system. 
Its functions related to bone homeostasis are the 
following intestinal calcium and phosphate absorption 
and decreased calcium and phosphate excretion by the 
kidneys. 1,25-(OH)2D3 increases calcium binding protein, 
calbindins and calcium channel TRPV6 production in the 
enterocytes which functions as a transporter for calcium 
across the cells and into the bloodstream. This protein is 
stored within cells even if 1 ,25-(OH)2D3 is excreted and so 
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calcium uptake continues. 1,25-(OH)2D3 also stimulates 
the formation of a calcium-stimulated ATPase as well as 
alkaline phosphatase which seem to promote calcium 
uptake. When vitamin D is present in great quantities, it 
causes absorption of bone by activating osteoblasts 
which in twn activate osteoclast action. However, in 
smaller quantities vitamin D causes bone calcification 
since, it increases bone mineralisation by modulating 
calcium influx and increasing calcium binding proteins 
such as osteocalcin and osteoportin in osteoblasts 
(Bouillon et 01.. 2008). 
THE VITAMIN D RECEPTOR (VDR) 
VDR expression and its actions in bone: VDR IS a 
receptor expressed by almost all cells in the body and 
belongs to the steroid receptor family. VDR functions by 
heterodimerisation together with any of the three isomers 
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Fig. 2: Vitamin D3 synthesis and its transport to target cells 
for Retinoid X Receptor (RXR) lacking the specific ligand 
9-cis-retinoic acid. When 1,25-(OH)2D3 binds to this 
complex, the active Ligand Binding Domain (LBD) is 
formed and this complex diffuses through the cell 
membrane as 1,25-(OH)2D3 is a lipid soluble hormone. 
Once this receptor is activated, a cascade of reactions 
occur including activation of the MAP-kinase (mitogen 
activated protein kinase) pathway and an intracellular 
increase in cyclic Adenosine Monophosphate (cA1.1P), 
Protein Kinase C (PKC) and opening of calciwn and 
chloride ch31lllels, resulting in a biological response. The 
main pathway for activation however, is through Vitamin 
D Response Element (VDRE) activation by binding of the 
LBD of the VDR to a specific region where zinc fingers 
seem to playa role of aiding this binding. This modulates 
gene expression in the nucleus and depending on the cell 
where it is active, different actions will be brought about. 
For instance in osteoblasts calcium and chloride channels 
open which are essential for bone mineralisation and the 
production of the plasma membrane protein Receptor 
Activator of NF-kB ligand (RANKL) which promotes 
osteoclast development. Furthermore in intestinal cells 
transcaltachia (rapid transport of calcium) and activation 
of 1.1AP-kinase, PKC and phospholipase C occurs 
(Norman, 2008). 
Polymorphisms of the VDR: A study by Bouillon et 01. 
(2008) was carried out to see the effects of mutations or 
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loss of VDRs in mice. It was fOlllld that these mice were 
suffering from severe hypocalcemia, osteomalacia and 
rickets as a result of imbalance in calcium and bone 
homeostasis due to 1.2S-(OH),D, (calcitriol) not being able 
to act on the receptors. Also, phosphate and PTH balance 
intestinal absorption and renal calcium reabsorption, seem 
to be processes dependent on calcitriol activated genes 
because the mice showed signs of hypophophatemia, 
secondary hyperparathyroidism, requirement of activation 
of genes coding for TRPV6. CaBP-9k. PMCA" in the 
intestine and TRPV5 in renal tubular epithelium. These 
transporters with the exception of TRPV5, do not seem to 
be entirely dependent on activation by the VDRE complex 
since the mice did not develop a significant decrease in 
calcium absorption. This could be due to the presence of 
other receptors in the enterocytes responsible for calcium 
uptake. 
Figure 2 shows the pathway taken from synthesis of 
vitamin D in the skin (forming inactive metabolites 
lumisterol and tachysterol when exposed to excess IN 
rays) to binding to vitamin D Binding Protein (DBP) and 
metabolism by cytochrome P450 oxidase in the liver 
(encoded by the gene CYP27AI). DBP canies 2S-(OH)D, 
to the kidneys where another cytochrome P450 oxidase 
this time encoded by CYF27Bl in the proximal tubules of 
the kidneys, produces 1,25-(OH)2D3. This dissociates from 
DBP once it reaches the target cell and binds to 
vitaminD Receptor (VDR). Within the nucleus. binding to 
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